Inventor · disambiguated record
Francis C. Zeigler
Also filed as: ZEIGLER FRANCIS C · ZEIGLER FRANCIS CHRISTOPHER
8 granted patents·6 pending applications·83 citations·filing 1994–2023
84Inventor score
Files withBREAKTHROUGH TECH LLC5HISTOGEN INC3ORION BIOSOLUTIONS INC3GENENTECH INC1PUR BIOLOGICS INC1
Top patents by PatentIndex Score
14 records- 0181US10508262B1Activation of immune cellsBREAKTHROUGH TECH LLC·Filed 2018·Granted Dec 17, 2019·1 cites·9 claims
- 0281US5635388AAgonist antibodies against the flk2/flt3 receptor and uses thereofGENENTECH INC·Filed 1994·Granted Jun 3, 1997·49 cites·15 claims
- 0378US2022204921A1Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditionsHISTOGEN INC·Filed 2022·Application pending·0 cites
- 0477US2024158746A1Activation of immune cellsBREAKTHROUGH TECH LLC·Filed 2023·Application pending·0 cites
- 0576US7018804B1Determination of cell viability and phenotypeORION BIOSOLUTIONS INC·Filed 2005·Granted Mar 28, 2006·9 cites·20 claims
- 0673US5997865AAgonist antibodies against the flk2/flt3 receptor and uses thereofFiled 1995·Granted Dec 7, 1999·24 cites·20 claims
- 0773US2024150717A1Methods and compositions for manufacturing extracellular matrixBREAKTHROUGH TECH LLC·Filed 2023·Application pending·0 cites
- 0871US11781111B2Activation of immune cellsBREAKTHROUGH TECH LLC·Filed 2019·Granted Oct 10, 2023·0 cites·10 claims
- 0970US11274276B2Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditionsHISTOGEN INC·Filed 2020·Granted Mar 15, 2022·0 cites·8 claims
- 1063US10538736B2Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditionsHISTOGEN INC·Filed 2016·Granted Jan 21, 2020·0 cites·7 claims
- 1156US11718829B2Methods and compositions for manufacturing extracellular matrixBREAKTHROUGH TECH LLC·Filed 2017·Granted Aug 8, 2023·0 cites·26 claims
- 1255US2023074374A1Methods of manufacturing extracellular matrix using aspartyl alanyl diketopiperazine (da-dkp)PUR BIOLOGICS INC·Filed 2021·Application pending·0 cites
- 1339US2006252149A1Cns cells in vitroORION BIOSOLUTIONS INC·Filed 2006·Application pending·0 cites
- 1436US2006121443A1Determination of cell viabilityORION BIOSOLUTIONS INC·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →